Singapore Biomedical Firms Raise Record $600m: Straits Times

Singapore-based biomedical companies raised a record $600 million (Singapore $820 million) between January and September, boosting the economy and the city-state’s status as a research and manufacturing hub, the Straits Times reported.

Data compiled by Enterprise Singapore showed that the amount raised increased more than five times from the $86 million in 2016 to $464 million last year.

Read the full report: Straits Times.

ALSO READ:

Singapore Growing Target for Ransomware Attacks: ST

Singapore Reports First Locally Transmitted Omicron Case

Singapore Now Asia’s Priciest City: Straits Times

Jim Pollard

Jim Pollard is an Australian journalist based in Thailand since 1999. He worked for News Ltd papers in Sydney, Perth, London and Melbourne before travelling through SE Asia in the late 90s. He was a senior editor at The Nation for 17+ years and has a family in Bangkok.

You Might also Like

Revised Bill Gives US Firms Time to Cut Ties With China Biotechs

Chinese Biotech Giant WuXi ‘Sent US Client’s Data to Beijing’

China Resources Eyes Botox Distributor in $3bn Take-Private Deal